HAPILA is engaged in three major business areas of the API value-creation chain: synthesis, purification and particle design; this makes HAPILA a highly efficient bridge-builder between production of the API and its suitability for pharmaceutical production.
Optimisation of established chemicals syntheses of active pharmaceutical ingredients
Development of synthesis processes
Manufacturing of active pharmaceutical ingredients under GMP conditions
Manufacturing of reference standard substances
Scale: laboratory (1 g) - pilot (100 g) - production (10 kg)
Regulatory: regulatorily relevant documents, GMP certified